Search Results - "Kruger, A E"

Refine Results
  1. 1

    Thalidomide neuropathy in patients treated for metastatic prostate cancer by Molloy, F.M., Floeter, M.K., Syed, N.A., Sandbrink, F., Culcea, E., Steinberg, S.M., Dahut, W., Pluda, J., Kruger, E.A., Reed, E., Figg, W.D.

    Published in Muscle & nerve (01-08-2001)
    “…We prospectively evaluated thalidomide‐induced neuropathy using electrodiagnostic studies. Sixty‐seven men with metastatic androgen‐independent prostate cancer…”
    Get full text
    Journal Article
  2. 2

    TNP-470: an angiogenesis inhibitor in clinical development for cancer by Kruger, E A, Figg, W D

    Published in Expert opinion on investigational drugs (01-06-2000)
    “…TNP-470, an analogue of fumagillin, has been shown to inhibit angiogenesis in vitro and in vivo. In 1992, TNP-470 entered clinical development for cancer as an…”
    Get more information
    Journal Article
  3. 3

    The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing by Berger, Adam C., Feldman, Andrew L., Gnant, Michael F.X., Kruger, Erwin A., Sim, B.Kim Lee, Hewitt, Stephen, Figg, William D., Alexander, H.Richard, Libutti, Steven K.

    Published in The Journal of surgical research (01-06-2000)
    “…Background. Endostatin is a potent angiogenesis inhibitor, which is currently being used in Phase I trials as an antitumor agent. The purpose of this study was…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    POSSIBLE PROSPECTS DEVELOPMENT OF THE MODERN INFECTIOLOGY by I. V. Bogadelnikov, E. A. Kruger, A. V. Bobrysheva, N. I. Muzhetskaya

    “…On the basis of current scientific evidence substantiated opinion about the primacy of the prokaryotes (bacteria and viruses) in the existence of human life…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program by Rietbergen, John B.W., Kruger, Arto E.Boeken, Kranse, Ries, Schröder, Fritz H.

    Published in Urology (Ridgewood, N.J.) (01-06-1997)
    “…Objectives. Screening for prostate cancer to reduce the mortality and morbidity from this disease has become an important issue in recent years. Of all…”
    Get full text
    Journal Article
  7. 7

    Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer by Rietbergen, J B, Kruger, A E, Hoedemaeker, R F, Bangma, C H, Kirkels, W J, Schröder, F H

    Published in The Journal of urology (01-12-1998)
    “…We describe the yield of a repeat examination and biopsy procedure 1 year after initial biopsy was negative. We also assessed the parameters responsible for…”
    Get more information
    Journal Article
  8. 8

    Evaluation of prostate needle biopsies in a population-based screening study : The impact of borderline lesions by HOEDEMAEKER, R. F, KRANSE, R, RIETBERGEN, J. B. W, KRUGER, A. E. B, SCHRÖDER, F. H, VAN DER KWAST, T. H

    Published in Cancer (1999)
    “…The finding of isolated high grade prostatic intraepithelial neoplasia (PIN) or borderline lesions (lesions suspicious for malignancy) in prostate needle…”
    Get full text
    Journal Article
  9. 9

    Approaches to preclinical screening of antiangiogenic agents by Kruger, E A, Duray, P H, Price, D K, Pluda, J M, Figg, W D

    Published in Seminars in oncology (01-12-2001)
    “…Angiogenesis, or new blood vessel growth, is essential for the growth, invasion, and metastasis of solid tumors. The inhibition of this process, or…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Endostatin Inhibits Microvessel Formation in the ex Vivo Rat Aortic Ring Angiogenesis Assay by Kruger, Erwin A., Duray, Paul H., Tsokos, Maria G., Venzon, David J., Libutti, Steven K., Dixon, Shannon C., Rudek, Michelle A., Pluda, James, Allegra, Carmen, Figg, William D.

    “…Endostatin has demonstrated potent antiangiogenic and antitumor activity in mouse models. We have investigated the ex vivo rat aortic ring assay and a human…”
    Get full text
    Journal Article
  12. 12

    Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues by NG, Sylvia S. W, GÜTSCHOW, Michael, WEISS, Michael, HAUSCHILDT, Sunna, TEUBERT, Uwe, HECKER, Thomas K, LUZZIO, Frederick A, KRUGER, Erwin A, EGER, Kurt, FIGG, William D

    Published in Cancer research (Chicago, Ill.) (15-06-2003)
    “…Inhibition of angiogenesis is currently perceived as one of the promising strategies in the treatment of cancer. The antiangiogenic property of thalidomide has…”
    Get full text
    Journal Article
  13. 13

    Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway by Bauer, K S, Cude, K J, Dixon, S C, Kruger, E A, Figg, W D

    “…The induction of angiogenesis is known to play a critical role in the successful growth, invasion, and metastasis of a tumor. A tumor will not grow beyond a…”
    Get more information
    Journal Article
  14. 14

    Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study by Rietbergen, John B.W, Kranse, Ries, Hoedemaeker, Robert F, Kruger, Arto E.Boeken, Bangma, Chris H, Kirkels, Wim J, Schröder, Fritz H

    Published in Urology (Ridgewood, N.J.) (01-08-1998)
    “…Objectives. To compare the discriminatory potential between prostate cancer and benign conditions of the prostate in a population-based screening study, of…”
    Get full text
    Journal Article
  15. 15

    Protein Binding Alters the Activity of Suramin, Carboxyamidotriazole, and UCN-01 in an ex Vivo Rat Aortic Ring Angiogenesis Assay by KRÜGER, Erwin A, FIGG, William D

    Published in Clinical cancer research (01-07-2001)
    “…Angiogenesis inhibitors are currently in clinical development for cancer. These agents pose unique developmental challenges: ( a ) determining maximum…”
    Get full text
    Journal Article
  16. 16

    Getting to Know Ourselves and Our Places Through Participation in Civic Social Assessment by Kruger, Linda E, Shannon, Margaret A

    Published in Society & natural resources (01-07-2000)
    “…Civic science (involving citizens as researchers) expands opportunities for learning among citizens, scientists, and managers. Citizens have knowledge that…”
    Get full text
    Journal Article
  17. 17

    Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells by Dixon, S C, Kruger, E A, Bauer, K S, Figg, W D

    Published in Cancer chemotherapy and pharmacology (01-05-1999)
    “…Thalidomide has been shown to have species- and metabolic-dependent antiangiogenic activity in vitro and in vivo, suggesting its potential in treating human…”
    Get full text
    Journal Article
  18. 18

    On the standardization of total prostate-specific antigen: an exercise with two reference preparations by Blijenberg, B G, Storm, B N, Kruger, A E, Schröder, F H

    Published in Clinical chemistry and laboratory medicine (01-05-1999)
    “…In this study, 112 serum samples were analyzed for total prostate-specific antigen with three well-established assays i.e. Tandem R and Tandem E (both from…”
    Get more information
    Journal Article
  19. 19

    Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay by Zogakis, T G, Costouros, N G, Kruger, E A, Forbes, S, He, M, Qian, M, Feldman, A L, Figg, W D, Alexander, H R, Liu, E T, Kohn, E C, Libutti, S K

    Published in BioTechniques (01-09-2002)
    “…The rat aortic ring assay has been previously described as a useful ex vivo model for analyzing the biological activity of various inhibitors of angiogenesis…”
    Get full text
    Journal Article
  20. 20

    The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study by Rietbergen, J B, Hoedemaeker, R F, Kruger, A E, Kirkels, W J, Schröder, F H

    Published in The Journal of urology (01-04-1999)
    “…We describe the clinical and pathological features of prostate cancer diagnosed through serum prostate specific antigen (PSA), digital rectal examination and…”
    Get more information
    Journal Article